[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Fragment-based Drug Discovery Market Research Report 2024(Status and Outlook)

September 2024 | 129 pages | ID: GD55ADA25361EN
Bosson Research

US$ 3,200.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Report Overview:

The introduction of new techniques into the existing fragment-based drug discovery practices have created significant reductions in time and cost, driving the demand for such practices.

The Global Fragment-based Drug Discovery Market Size was estimated at USD 366.60 million in 2023 and is projected to reach USD 534.92 million by 2029, exhibiting a CAGR of 6.50% during the forecast period.

This report provides a deep insight into the global Fragment-based Drug Discovery market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Fragment-based Drug Discovery Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Fragment-based Drug Discovery market in any manner.

Global Fragment-based Drug Discovery Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Astex Pharmaceuticals

Alveus Pharmaceuticals

Beactica

Charles River Laboratories

Crown Bioscience

Emerald BioStructures

Evotec

Kinetic Discovery

Proteros Fragments

Sprint Bioscience

Structure Based Design

Sygnature Discovery

Market Segmentation (by Type)

Fragment Screening

Fragment Optimization

Market Segmentation (by Application)

Academic and Research Institutions

Biopharmaceutical Companies

Contract Research Organizations (CROs)

Geographic Segmentation
  • North America (USA, Canada, Mexico)
  • Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
  • Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
  • South America (Brazil, Argentina, Columbia, Rest of South America)
  • The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
  • Industry drivers, restraints, and opportunities covered in the study
  • Neutral perspective on the market performance
  • Recent industry trends and developments
  • Competitive landscape & strategies of key players
  • Potential & niche segments and regions exhibiting promising growth covered
  • Historical, current, and projected market size, in terms of value
  • In-depth analysis of the Fragment-based Drug Discovery Market
  • Overview of the regional outlook of the Fragment-based Drug Discovery Market:
Key Reasons to Buy this Report:
  • Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
  • This enables you to anticipate market changes to remain ahead of your competitors
  • You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
  • The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
  • Provision of market value (USD Billion) data for each segment and sub-segment
  • Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
  • Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
  • Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
  • Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
  • The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
  • Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
  • Provides insight into the market through Value Chain
  • Market dynamics scenario, along with growth opportunities of the market in the years to come
  • 6-month post-sales analyst support
Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Note: this report may need to undergo a final check or review and this could take about 48 hours.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Fragment-based Drug Discovery Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE

1.1 Market Definition and Statistical Scope of Fragment-based Drug Discovery
1.2 Key Market Segments
  1.2.1 Fragment-based Drug Discovery Segment by Type
  1.2.2 Fragment-based Drug Discovery Segment by Application
1.3 Methodology & Sources of Information
  1.3.1 Research Methodology
  1.3.2 Research Process
  1.3.3 Market Breakdown and Data Triangulation
  1.3.4 Base Year
  1.3.5 Report Assumptions & Caveats

2 FRAGMENT-BASED DRUG DISCOVERY MARKET OVERVIEW

2.1 Global Market Overview
  2.1.1 Global Fragment-based Drug Discovery Market Size (M USD) Estimates and Forecasts (2019-2030)
  2.1.2 Global Fragment-based Drug Discovery Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region

3 FRAGMENT-BASED DRUG DISCOVERY MARKET COMPETITIVE LANDSCAPE

3.1 Global Fragment-based Drug Discovery Sales by Manufacturers (2019-2024)
3.2 Global Fragment-based Drug Discovery Revenue Market Share by Manufacturers (2019-2024)
3.3 Fragment-based Drug Discovery Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Fragment-based Drug Discovery Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Fragment-based Drug Discovery Sales Sites, Area Served, Product Type
3.6 Fragment-based Drug Discovery Market Competitive Situation and Trends
  3.6.1 Fragment-based Drug Discovery Market Concentration Rate
  3.6.2 Global 5 and 10 Largest Fragment-based Drug Discovery Players Market Share by Revenue
  3.6.3 Mergers & Acquisitions, Expansion

4 FRAGMENT-BASED DRUG DISCOVERY INDUSTRY CHAIN ANALYSIS

4.1 Fragment-based Drug Discovery Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis

5 THE DEVELOPMENT AND DYNAMICS OF FRAGMENT-BASED DRUG DISCOVERY MARKET

5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
  5.5.1 New Product Developments
  5.5.2 Mergers & Acquisitions
  5.5.3 Expansions
  5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies

6 FRAGMENT-BASED DRUG DISCOVERY MARKET SEGMENTATION BY TYPE

6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Fragment-based Drug Discovery Sales Market Share by Type (2019-2024)
6.3 Global Fragment-based Drug Discovery Market Size Market Share by Type (2019-2024)
6.4 Global Fragment-based Drug Discovery Price by Type (2019-2024)

7 FRAGMENT-BASED DRUG DISCOVERY MARKET SEGMENTATION BY APPLICATION

7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Fragment-based Drug Discovery Market Sales by Application (2019-2024)
7.3 Global Fragment-based Drug Discovery Market Size (M USD) by Application (2019-2024)
7.4 Global Fragment-based Drug Discovery Sales Growth Rate by Application (2019-2024)

8 FRAGMENT-BASED DRUG DISCOVERY MARKET SEGMENTATION BY REGION

8.1 Global Fragment-based Drug Discovery Sales by Region
  8.1.1 Global Fragment-based Drug Discovery Sales by Region
  8.1.2 Global Fragment-based Drug Discovery Sales Market Share by Region
8.2 North America
  8.2.1 North America Fragment-based Drug Discovery Sales by Country
  8.2.2 U.S.
  8.2.3 Canada
  8.2.4 Mexico
8.3 Europe
  8.3.1 Europe Fragment-based Drug Discovery Sales by Country
  8.3.2 Germany
  8.3.3 France
  8.3.4 U.K.
  8.3.5 Italy
  8.3.6 Russia
8.4 Asia Pacific
  8.4.1 Asia Pacific Fragment-based Drug Discovery Sales by Region
  8.4.2 China
  8.4.3 Japan
  8.4.4 South Korea
  8.4.5 India
  8.4.6 Southeast Asia
8.5 South America
  8.5.1 South America Fragment-based Drug Discovery Sales by Country
  8.5.2 Brazil
  8.5.3 Argentina
  8.5.4 Columbia
8.6 Middle East and Africa
  8.6.1 Middle East and Africa Fragment-based Drug Discovery Sales by Region
  8.6.2 Saudi Arabia
  8.6.3 UAE
  8.6.4 Egypt
  8.6.5 Nigeria
  8.6.6 South Africa

9 KEY COMPANIES PROFILE

9.1 Astex Pharmaceuticals
  9.1.1 Astex Pharmaceuticals Fragment-based Drug Discovery Basic Information
  9.1.2 Astex Pharmaceuticals Fragment-based Drug Discovery Product Overview
  9.1.3 Astex Pharmaceuticals Fragment-based Drug Discovery Product Market Performance
  9.1.4 Astex Pharmaceuticals Business Overview
  9.1.5 Astex Pharmaceuticals Fragment-based Drug Discovery SWOT Analysis
  9.1.6 Astex Pharmaceuticals Recent Developments
9.2 Alveus Pharmaceuticals
  9.2.1 Alveus Pharmaceuticals Fragment-based Drug Discovery Basic Information
  9.2.2 Alveus Pharmaceuticals Fragment-based Drug Discovery Product Overview
  9.2.3 Alveus Pharmaceuticals Fragment-based Drug Discovery Product Market Performance
  9.2.4 Alveus Pharmaceuticals Business Overview
  9.2.5 Alveus Pharmaceuticals Fragment-based Drug Discovery SWOT Analysis
  9.2.6 Alveus Pharmaceuticals Recent Developments
9.3 Beactica
  9.3.1 Beactica Fragment-based Drug Discovery Basic Information
  9.3.2 Beactica Fragment-based Drug Discovery Product Overview
  9.3.3 Beactica Fragment-based Drug Discovery Product Market Performance
  9.3.4 Beactica Fragment-based Drug Discovery SWOT Analysis
  9.3.5 Beactica Business Overview
  9.3.6 Beactica Recent Developments
9.4 Charles River Laboratories
  9.4.1 Charles River Laboratories Fragment-based Drug Discovery Basic Information
  9.4.2 Charles River Laboratories Fragment-based Drug Discovery Product Overview
  9.4.3 Charles River Laboratories Fragment-based Drug Discovery Product Market Performance
  9.4.4 Charles River Laboratories Business Overview
  9.4.5 Charles River Laboratories Recent Developments
9.5 Crown Bioscience
  9.5.1 Crown Bioscience Fragment-based Drug Discovery Basic Information
  9.5.2 Crown Bioscience Fragment-based Drug Discovery Product Overview
  9.5.3 Crown Bioscience Fragment-based Drug Discovery Product Market Performance
  9.5.4 Crown Bioscience Business Overview
  9.5.5 Crown Bioscience Recent Developments
9.6 Emerald BioStructures
  9.6.1 Emerald BioStructures Fragment-based Drug Discovery Basic Information
  9.6.2 Emerald BioStructures Fragment-based Drug Discovery Product Overview
  9.6.3 Emerald BioStructures Fragment-based Drug Discovery Product Market Performance
  9.6.4 Emerald BioStructures Business Overview
  9.6.5 Emerald BioStructures Recent Developments
9.7 Evotec
  9.7.1 Evotec Fragment-based Drug Discovery Basic Information
  9.7.2 Evotec Fragment-based Drug Discovery Product Overview
  9.7.3 Evotec Fragment-based Drug Discovery Product Market Performance
  9.7.4 Evotec Business Overview
  9.7.5 Evotec Recent Developments
9.8 Kinetic Discovery
  9.8.1 Kinetic Discovery Fragment-based Drug Discovery Basic Information
  9.8.2 Kinetic Discovery Fragment-based Drug Discovery Product Overview
  9.8.3 Kinetic Discovery Fragment-based Drug Discovery Product Market Performance
  9.8.4 Kinetic Discovery Business Overview
  9.8.5 Kinetic Discovery Recent Developments
9.9 Proteros Fragments
  9.9.1 Proteros Fragments Fragment-based Drug Discovery Basic Information
  9.9.2 Proteros Fragments Fragment-based Drug Discovery Product Overview
  9.9.3 Proteros Fragments Fragment-based Drug Discovery Product Market Performance
  9.9.4 Proteros Fragments Business Overview
  9.9.5 Proteros Fragments Recent Developments
9.10 Sprint Bioscience
  9.10.1 Sprint Bioscience Fragment-based Drug Discovery Basic Information
  9.10.2 Sprint Bioscience Fragment-based Drug Discovery Product Overview
  9.10.3 Sprint Bioscience Fragment-based Drug Discovery Product Market Performance
  9.10.4 Sprint Bioscience Business Overview
  9.10.5 Sprint Bioscience Recent Developments
9.11 Structure Based Design
  9.11.1 Structure Based Design Fragment-based Drug Discovery Basic Information
  9.11.2 Structure Based Design Fragment-based Drug Discovery Product Overview
  9.11.3 Structure Based Design Fragment-based Drug Discovery Product Market Performance
  9.11.4 Structure Based Design Business Overview
  9.11.5 Structure Based Design Recent Developments
9.12 Sygnature Discovery
  9.12.1 Sygnature Discovery Fragment-based Drug Discovery Basic Information
  9.12.2 Sygnature Discovery Fragment-based Drug Discovery Product Overview
  9.12.3 Sygnature Discovery Fragment-based Drug Discovery Product Market Performance
  9.12.4 Sygnature Discovery Business Overview
  9.12.5 Sygnature Discovery Recent Developments

10 FRAGMENT-BASED DRUG DISCOVERY MARKET FORECAST BY REGION

10.1 Global Fragment-based Drug Discovery Market Size Forecast
10.2 Global Fragment-based Drug Discovery Market Forecast by Region
  10.2.1 North America Market Size Forecast by Country
  10.2.2 Europe Fragment-based Drug Discovery Market Size Forecast by Country
  10.2.3 Asia Pacific Fragment-based Drug Discovery Market Size Forecast by Region
  10.2.4 South America Fragment-based Drug Discovery Market Size Forecast by Country
  10.2.5 Middle East and Africa Forecasted Consumption of Fragment-based Drug Discovery by Country

11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)

11.1 Global Fragment-based Drug Discovery Market Forecast by Type (2025-2030)
  11.1.1 Global Forecasted Sales of Fragment-based Drug Discovery by Type (2025-2030)
  11.1.2 Global Fragment-based Drug Discovery Market Size Forecast by Type (2025-2030)
  11.1.3 Global Forecasted Price of Fragment-based Drug Discovery by Type (2025-2030)
11.2 Global Fragment-based Drug Discovery Market Forecast by Application (2025-2030)
  11.2.1 Global Fragment-based Drug Discovery Sales (K Units) Forecast by Application
  11.2.2 Global Fragment-based Drug Discovery Market Size (M USD) Forecast by Application (2025-2030)

12 CONCLUSION AND KEY FINDINGS

LIST OF TABLES

Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Fragment-based Drug Discovery Market Size Comparison by Region (M USD)
Table 5. Global Fragment-based Drug Discovery Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Fragment-based Drug Discovery Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Fragment-based Drug Discovery Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Fragment-based Drug Discovery Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Fragment-based Drug Discovery as of 2022)
Table 10. Global Market Fragment-based Drug Discovery Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Fragment-based Drug Discovery Sales Sites and Area Served
Table 12. Manufacturers Fragment-based Drug Discovery Product Type
Table 13. Global Fragment-based Drug Discovery Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Fragment-based Drug Discovery
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Fragment-based Drug Discovery Market Challenges
Table 22. Global Fragment-based Drug Discovery Sales by Type (K Units)
Table 23. Global Fragment-based Drug Discovery Market Size by Type (M USD)
Table 24. Global Fragment-based Drug Discovery Sales (K Units) by Type (2019-2024)
Table 25. Global Fragment-based Drug Discovery Sales Market Share by Type (2019-2024)
Table 26. Global Fragment-based Drug Discovery Market Size (M USD) by Type (2019-2024)
Table 27. Global Fragment-based Drug Discovery Market Size Share by Type (2019-2024)
Table 28. Global Fragment-based Drug Discovery Price (USD/Unit) by Type (2019-2024)
Table 29. Global Fragment-based Drug Discovery Sales (K Units) by Application
Table 30. Global Fragment-based Drug Discovery Market Size by Application
Table 31. Global Fragment-based Drug Discovery Sales by Application (2019-2024) & (K Units)
Table 32. Global Fragment-based Drug Discovery Sales Market Share by Application (2019-2024)
Table 33. Global Fragment-based Drug Discovery Sales by Application (2019-2024) & (M USD)
Table 34. Global Fragment-based Drug Discovery Market Share by Application (2019-2024)
Table 35. Global Fragment-based Drug Discovery Sales Growth Rate by Application (2019-2024)
Table 36. Global Fragment-based Drug Discovery Sales by Region (2019-2024) & (K Units)
Table 37. Global Fragment-based Drug Discovery Sales Market Share by Region (2019-2024)
Table 38. North America Fragment-based Drug Discovery Sales by Country (2019-2024) & (K Units)
Table 39. Europe Fragment-based Drug Discovery Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Fragment-based Drug Discovery Sales by Region (2019-2024) & (K Units)
Table 41. South America Fragment-based Drug Discovery Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Fragment-based Drug Discovery Sales by Region (2019-2024) & (K Units)
Table 43. Astex Pharmaceuticals Fragment-based Drug Discovery Basic Information
Table 44. Astex Pharmaceuticals Fragment-based Drug Discovery Product Overview
Table 45. Astex Pharmaceuticals Fragment-based Drug Discovery Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Astex Pharmaceuticals Business Overview
Table 47. Astex Pharmaceuticals Fragment-based Drug Discovery SWOT Analysis
Table 48. Astex Pharmaceuticals Recent Developments
Table 49. Alveus Pharmaceuticals Fragment-based Drug Discovery Basic Information
Table 50. Alveus Pharmaceuticals Fragment-based Drug Discovery Product Overview
Table 51. Alveus Pharmaceuticals Fragment-based Drug Discovery Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Alveus Pharmaceuticals Business Overview
Table 53. Alveus Pharmaceuticals Fragment-based Drug Discovery SWOT Analysis
Table 54. Alveus Pharmaceuticals Recent Developments
Table 55. Beactica Fragment-based Drug Discovery Basic Information
Table 56. Beactica Fragment-based Drug Discovery Product Overview
Table 57. Beactica Fragment-based Drug Discovery Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Beactica Fragment-based Drug Discovery SWOT Analysis
Table 59. Beactica Business Overview
Table 60. Beactica Recent Developments
Table 61. Charles River Laboratories Fragment-based Drug Discovery Basic Information
Table 62. Charles River Laboratories Fragment-based Drug Discovery Product Overview
Table 63. Charles River Laboratories Fragment-based Drug Discovery Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Charles River Laboratories Business Overview
Table 65. Charles River Laboratories Recent Developments
Table 66. Crown Bioscience Fragment-based Drug Discovery Basic Information
Table 67. Crown Bioscience Fragment-based Drug Discovery Product Overview
Table 68. Crown Bioscience Fragment-based Drug Discovery Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Crown Bioscience Business Overview
Table 70. Crown Bioscience Recent Developments
Table 71. Emerald BioStructures Fragment-based Drug Discovery Basic Information
Table 72. Emerald BioStructures Fragment-based Drug Discovery Product Overview
Table 73. Emerald BioStructures Fragment-based Drug Discovery Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Emerald BioStructures Business Overview
Table 75. Emerald BioStructures Recent Developments
Table 76. Evotec Fragment-based Drug Discovery Basic Information
Table 77. Evotec Fragment-based Drug Discovery Product Overview
Table 78. Evotec Fragment-based Drug Discovery Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Evotec Business Overview
Table 80. Evotec Recent Developments
Table 81. Kinetic Discovery Fragment-based Drug Discovery Basic Information
Table 82. Kinetic Discovery Fragment-based Drug Discovery Product Overview
Table 83. Kinetic Discovery Fragment-based Drug Discovery Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Kinetic Discovery Business Overview
Table 85. Kinetic Discovery Recent Developments
Table 86. Proteros Fragments Fragment-based Drug Discovery Basic Information
Table 87. Proteros Fragments Fragment-based Drug Discovery Product Overview
Table 88. Proteros Fragments Fragment-based Drug Discovery Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Proteros Fragments Business Overview
Table 90. Proteros Fragments Recent Developments
Table 91. Sprint Bioscience Fragment-based Drug Discovery Basic Information
Table 92. Sprint Bioscience Fragment-based Drug Discovery Product Overview
Table 93. Sprint Bioscience Fragment-based Drug Discovery Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Sprint Bioscience Business Overview
Table 95. Sprint Bioscience Recent Developments
Table 96. Structure Based Design Fragment-based Drug Discovery Basic Information
Table 97. Structure Based Design Fragment-based Drug Discovery Product Overview
Table 98. Structure Based Design Fragment-based Drug Discovery Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Structure Based Design Business Overview
Table 100. Structure Based Design Recent Developments
Table 101. Sygnature Discovery Fragment-based Drug Discovery Basic Information
Table 102. Sygnature Discovery Fragment-based Drug Discovery Product Overview
Table 103. Sygnature Discovery Fragment-based Drug Discovery Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. Sygnature Discovery Business Overview
Table 105. Sygnature Discovery Recent Developments
Table 106. Global Fragment-based Drug Discovery Sales Forecast by Region (2025-2030) & (K Units)
Table 107. Global Fragment-based Drug Discovery Market Size Forecast by Region (2025-2030) & (M USD)
Table 108. North America Fragment-based Drug Discovery Sales Forecast by Country (2025-2030) & (K Units)
Table 109. North America Fragment-based Drug Discovery Market Size Forecast by Country (2025-2030) & (M USD)
Table 110. Europe Fragment-based Drug Discovery Sales Forecast by Country (2025-2030) & (K Units)
Table 111. Europe Fragment-based Drug Discovery Market Size Forecast by Country (2025-2030) & (M USD)
Table 112. Asia Pacific Fragment-based Drug Discovery Sales Forecast by Region (2025-2030) & (K Units)
Table 113. Asia Pacific Fragment-based Drug Discovery Market Size Forecast by Region (2025-2030) & (M USD)
Table 114. South America Fragment-based Drug Discovery Sales Forecast by Country (2025-2030) & (K Units)
Table 115. South America Fragment-based Drug Discovery Market Size Forecast by Country (2025-2030) & (M USD)
Table 116. Middle East and Africa Fragment-based Drug Discovery Consumption Forecast by Country (2025-2030) & (Units)
Table 117. Middle East and Africa Fragment-based Drug Discovery Market Size Forecast by Country (2025-2030) & (M USD)
Table 118. Global Fragment-based Drug Discovery Sales Forecast by Type (2025-2030) & (K Units)
Table 119. Global Fragment-based Drug Discovery Market Size Forecast by Type (2025-2030) & (M USD)
Table 120. Global Fragment-based Drug Discovery Price Forecast by Type (2025-2030) & (USD/Unit)
Table 121. Global Fragment-based Drug Discovery Sales (K Units) Forecast by Application (2025-2030)
Table 122. Global Fragment-based Drug Discovery Market Size Forecast by Application (2025-2030) & (M USD)

LIST OF FIGURES

Figure 1. Product Picture of Fragment-based Drug Discovery
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Fragment-based Drug Discovery Market Size (M USD), 2019-2030
Figure 5. Global Fragment-based Drug Discovery Market Size (M USD) (2019-2030)
Figure 6. Global Fragment-based Drug Discovery Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Fragment-based Drug Discovery Market Size by Country (M USD)
Figure 11. Fragment-based Drug Discovery Sales Share by Manufacturers in 2023
Figure 12. Global Fragment-based Drug Discovery Revenue Share by Manufacturers in 2023
Figure 13. Fragment-based Drug Discovery Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Fragment-based Drug Discovery Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Fragment-based Drug Discovery Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Fragment-based Drug Discovery Market Share by Type
Figure 18. Sales Market Share of Fragment-based Drug Discovery by Type (2019-2024)
Figure 19. Sales Market Share of Fragment-based Drug Discovery by Type in 2023
Figure 20. Market Size Share of Fragment-based Drug Discovery by Type (2019-2024)
Figure 21. Market Size Market Share of Fragment-based Drug Discovery by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Fragment-based Drug Discovery Market Share by Application
Figure 24. Global Fragment-based Drug Discovery Sales Market Share by Application (2019-2024)
Figure 25. Global Fragment-based Drug Discovery Sales Market Share by Application in 2023
Figure 26. Global Fragment-based Drug Discovery Market Share by Application (2019-2024)
Figure 27. Global Fragment-based Drug Discovery Market Share by Application in 2023
Figure 28. Global Fragment-based Drug Discovery Sales Growth Rate by Application (2019-2024)
Figure 29. Global Fragment-based Drug Discovery Sales Market Share by Region (2019-2024)
Figure 30. North America Fragment-based Drug Discovery Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Fragment-based Drug Discovery Sales Market Share by Country in 2023
Figure 32. U.S. Fragment-based Drug Discovery Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Fragment-based Drug Discovery Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Fragment-based Drug Discovery Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Fragment-based Drug Discovery Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Fragment-based Drug Discovery Sales Market Share by Country in 2023
Figure 37. Germany Fragment-based Drug Discovery Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Fragment-based Drug Discovery Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Fragment-based Drug Discovery Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Fragment-based Drug Discovery Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Fragment-based Drug Discovery Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Fragment-based Drug Discovery Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Fragment-based Drug Discovery Sales Market Share by Region in 2023
Figure 44. China Fragment-based Drug Discovery Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Fragment-based Drug Discovery Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Fragment-based Drug Discovery Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Fragment-based Drug Discovery Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Fragment-based Drug Discovery Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Fragment-based Drug Discovery Sales and Growth Rate (K Units)
Figure 50. South America Fragment-based Drug Discovery Sales Market Share by Country in 2023
Figure 51. Brazil Fragment-based Drug Discovery Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Fragment-based Drug Discovery Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Fragment-based Drug Discovery Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Fragment-based Drug Discovery Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Fragment-based Drug Discovery Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Fragment-based Drug Discovery Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Fragment-based Drug Discovery Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Fragment-based Drug Discovery Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Fragment-based Drug Discovery Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Fragment-based Drug Discovery Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Fragment-based Drug Discovery Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Fragment-based Drug Discovery Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Fragment-based Drug Discovery Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Fragment-based Drug Discovery Market Share Forecast by Type (2025-2030)
Figure 65. Global Fragment-based Drug Discovery Sales Forecast by Application (2025-2030)
Figure 66. Global Fragment-based Drug Discovery Market Share Forecast by Application (2025-2030)


More Publications